The Fort Worth Press - Drs. Todd H. Lanman and Joel S. Beckett Perform First Clinical Case Using Newly FDA-Approved Synergy Disc(R)

USD -
AED 3.672496
AFN 63.999637
ALL 81.031648
AMD 363.340421
ANG 1.790365
AOA 918.00039
ARS 1524.754198
AUD 1.42291
AWG 1.8
AZN 1.705597
BAM 1.7198
BBD 2.014334
BDT 123.134148
BGN 1.683441
BHD 0.376974
BIF 2996.596875
BMD 1
BND 1.278343
BOB 12.245759
BRL 5.213957
BSD 1.000132
BTN 95.938305
BWP 13.673816
BYN 3.027326
BYR 19600
BZD 2.011326
CAD 1.41705
CDF 2340.000016
CHF 0.831345
CLF 0.024498
CLP 967.330009
CNY 6.71325
CNH 6.71147
COP 3369.37
CRC 454.20569
CUC 1
CUP 24.002462
CVE 96.96141
CZK 21.428982
DJF 177.720211
DKK 6.57103
DOP 59.542287
DZD 133.831434
EGP 52.098498
ERN 15
ETB 162.972098
EUR 0.87899
FJD 2.2357
FKP 0.754816
GBP 0.753755
GEL 2.615005
GGP 0.754816
GHS 11.635494
GIP 0.754816
GMD 73.502842
GNF 8795.170658
GTQ 7.637958
GYD 209.257745
HKD 7.845065
HNL 26.846287
HRK 6.623098
HTG 130.885748
HUF 322.531034
IDR 18028
ILS 3.079601
IMP 0.754816
INR 95.93595
IQD 1310.042516
IRR 1374837.501412
ISK 120.430169
JEP 0.754816
JMD 158.315197
JOD 0.708997
JPY 157.244022
KES 129.729755
KGS 87.448502
KHR 4059.056814
KMF 433.000183
KPW 900.000318
KRW 1359.710329
KWD 0.30877
KYD 0.833443
KZT 439.793707
LAK 22439.127338
LBP 89556.106612
LKR 331.022111
LRD 172.008688
LSL 16.434096
LTL 2.95274
LVL 0.60489
LYD 6.397263
MAD 9.630717
MDL 17.680991
MGA 4387.052523
MKD 54.140561
MMK 2099.83552
MNT 3596.071123
MOP 8.080829
MRU 40.062785
MUR 47.469788
MVR 15.449932
MWK 1734.1564
MXN 17.85501
MYR 4.081702
MZN 63.909937
NAD 16.434096
NGN 1327.039625
NIO 36.800429
NOK 9.53582
NPR 153.505837
NZD 1.762425
OMR 0.384496
PAB 1.000079
PEN 3.398334
PGK 4.52425
PHP 62.465498
PKR 277.095071
PLN 3.839965
PYG 5873.947548
QAR 3.645277
RON 4.639494
RSD 103.307008
RUB 84.497761
RWF 1476.596231
SAR 3.755913
SBD 8.000512
SCR 13.873396
SDG 601.497925
SEK 9.94721
SGD 1.276995
SHP 0.755002
SLE 24.650298
SLL 20969.491881
SOS 571.60445
SRD 37.686023
STD 20697.981008
STN 21.545091
SVC 8.750324
SYP 13002.000254
SZL 16.429972
THB 33.563002
TJS 9.225649
TMT 3.51
TND 2.961507
TOP 2.40776
TRY 48.980798
TTD 6.787754
TWD 31.767976
TZS 2635.00303
UAH 44.876871
UGX 3914.861437
UYU 40.089518
UZS 11815.811573
VES 852.43145
VND 25974.5
VUV 117.801098
WST 2.745718
XAF 576.579692
XAG 0.01632
XAU 0.000241767514
XCD 2.70255
XCG 1.802386
XDR 0.707052
XOF 576.579692
XPF 104.870231
YER 236.649809
ZAR 16.393875
ZMK 9001.204285
ZMW 19.476614
ZWL 321.999592
SSP 5712.591902
MXV 2.022034
  • RIO

    -0.3300

    97.04

    -0.34%

  • CMSC

    -0.0400

    20.67

    -0.19%

  • RELX

    0.0000

    33.41

    0%

  • RBGPF

    0.0000

    67.95

    0%

  • BCE

    -0.0700

    21.99

    -0.32%

  • BCC

    -0.0300

    75.66

    -0.04%

  • GSK

    0.8600

    51.08

    +1.68%

  • JRI

    -0.0300

    11.52

    -0.26%

  • NGG

    -0.1200

    76.68

    -0.16%

  • CMSD

    0.0900

    20.54

    +0.44%

  • BTI

    -0.0800

    55.75

    -0.14%

  • AZN

    2.0200

    168.1

    +1.2%

  • BP

    -1.4200

    43.16

    -3.29%

  • RYCEF

    0.4600

    19.7

    +2.34%

  • VOD

    0.0700

    17.02

    +0.41%

Drs. Todd H. Lanman and Joel S. Beckett Perform First Clinical Case Using Newly FDA-Approved Synergy Disc(R)
Drs. Todd H. Lanman and Joel S. Beckett Perform First Clinical Case Using Newly FDA-Approved Synergy Disc(R)

Drs. Todd H. Lanman and Joel S. Beckett Perform First Clinical Case Using Newly FDA-Approved Synergy Disc(R)

Beverly Hills spine surgeons complete three-level cervical disc replacement following recent FDA approval of motion-preserving technology

Text size:

BEVERLY HILLS, CA / ACCESS Newswire / April 8, 2026 / Todd H. Lanman, MD, and Joel S. Beckett, MD have performed the first post-approval case using the newly FDA-approved Synergy Disc®, marking an early clinical milestone for the motion-preserving cervical disc technology.

The procedure was performed on Monday at the Advanced Surgery Center of Beverly Hills five weeks after the U.S. Food and Drug Administration (FDA) granted Premarket Approval (PMA) for the Synergy Disc® for single-level cervical disc replacement from C3-C7.

The patient, a 47-year-old man, presented with progressive neck pain, arm pain, and weakness in the setting of spinal cord compression and severe nerve root compression with associated bone spur formation. After failing conservative management, the patient was taken to surgery for a three-level cervical disc replacement to decompress the spinal cord, relieve nerve compression, and remove osteophytic pathology.

"This case reflects the continued evolution of motion-preserving spine surgery," said Dr. Lanman. "The ability to address complex pathology while preserving motion is central to how we think about treating cervical degenerative disease."

Dr. Beckett added, "With the recent FDA approval of the Synergy Disc, we now have access to a technology designed not only to preserve motion but also to support segmental alignment. That combination is important as we continue to refine surgical decision-making in cervical spine care."

The Synergy Disc® is a motion-preserving artificial cervical disc developed by Synergy Spine Solutions and engineered with a lordotic polyethylene core designed to maintain and restore physiologic alignment while allowing controlled motion. The Synergy Disc® is the only artificial cervical disc currently available that combines motion preservation with intentional alignment correction in a single device. The device recently demonstrated superiority to anterior cervical discectomy and fusion (ACDF) in a U.S. Investigational Device Exemption (IDE) clinical trial.

The patient is recovering well following surgery with early reduction in pain. Neurologic recovery will be assessed over time as healing progresses.

This first U.S. case represents an early step in the clinical adoption of the Synergy Disc®, with broader utilization expected as surgeons gain experience with the newly approved technology.

About Dr. Todd Lanman

Todd Lanman, MD has over three decades of experience as a spinal neurosurgeon and has spent the last 25 years practicing spine surgery in Beverly Hills. In addition to being a world-renowned spinal surgeon, Dr. Lanman has also had 11 spinal surgeries including spinal fusions and artificial disc replacements. Because of these experiences as surgeon and as patient, Dr. Lanman brings a unique perspective to his surgical practice.

About Dr. Joel S. Beckett

Joel S. Beckett, MD is a board-certified, dual fellowship-trained neurosurgeon specializing in complex spinal reconstruction, artificial disc replacement, and motion-preserving spine surgery. Educated at Yale, trained at UCLA, and refined at the Cleveland Clinic, Dr. Beckett combines rigorous academic training with advanced surgical technique. He is a former Director of Neurosurgical Spinal Oncology at UCLA and has authored more than 50 scientific publications, including work in AI-enhanced imaging and surgical planning.

About Lanman Spinal Neurosurgery

Lanman Spinal Neurosurgery is committed to improving patients' quality of life by relieving pain and restoring spinal motion. The Beverly Hills practice has been at the leading edge of spine health for the past quarter of a century. Lanman Spinal Neurosurgery has and continues to pioneer artificial disc replacement and fusion revision surgeries to help neck and back pain sufferers live their best lives.

About Beckett NeuroSpine

Beckett NeuroSpine is a specialty spine practice dedicated to the comprehensive treatment of spine disorders including complex and reconstructive spinal conditions. Led by dual fellowship-trained neurosurgeon Joel S. Beckett, MD, the practice emphasizes motion-preserving and minimally invasive techniques whenever appropriate while providing full spectrum spine care. Beckett NeuroSpine integrates advanced surgical planning, modern imaging technologies, and a patient-centered approach to deliver individualized treatment and restore function for patients with both routine and complex spinal pathology.

About Synergy Spine Solutions

The vision of Synergy Spine Solutions is to identify and commercialize innovative spine technologies that help surgeons improve their patients' quality of life and advance the standard of care. The company's flagship product, the Synergy Disc®, is the only device designed to restore both motion and alignment to the spine. For more information, visit www.synergyspinesolutions.com.

MEDIA CONTACT:
Brandi Kamenar
Brandi Kamenar Brand Management
BrandiKamenar.com
[email protected]
(310) 734-6180

SOURCE: Lanman Spinal Neurosurgery



View the original press release on ACCESS Newswire

J.P.Estrada--TFWP